Anastrozole

About

Therapy type: Hormone therapy

Therapy strategy: Aromatase inhibition

Mappings

NCI Thesaurus: Anastrozole (ncit:C1607)

RxNorm: anastrozole (rxcui:84857, omop:4297546)

SNOMED: Anastrozole (sctid:386910003, omop:1348265)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s)	Biomarker(s)	Cancer type	Therapy(ies)
EMA (2) FDA (2) HSE (1)	ER positive, HER2-negative	Invasive Breast Carcinoma	Abemaciclib, Anastrozole
EMA (2) FDA (2) HSE (1)	HER2-negative, PR positive	Invasive Breast Carcinoma	Abemaciclib, Anastrozole
EMA (2) FDA (2) HSE (1)	ER positive, HER2-negative, PR positive	Invasive Breast Carcinoma	Abemaciclib, Anastrozole
FDA (1)	ER positive, HER2-negative	Invasive Breast Carcinoma	Anastrozole, Ribociclib
FDA (1)	HER2-negative, PR positive	Invasive Breast Carcinoma	Anastrozole, Ribociclib
FDA (1)	ER positive, HER2-negative, PR positive	Invasive Breast Carcinoma	Anastrozole, Ribociclib
EMA (1) FDA (1) HSE (1)	ER positive, HER2-negative	Invasive Breast Carcinoma	Anastrozole, Goserelin, Ribociclib
EMA (1) FDA (1) HSE (1)	HER2-negative, PR positive	Invasive Breast Carcinoma	Anastrozole, Goserelin, Ribociclib
EMA (1) FDA (1) HSE (1)	ER positive, HER2-negative, PR positive	Invasive Breast Carcinoma	Anastrozole, Goserelin, Ribociclib
EMA (1)	HER2-positive	Invasive Breast Carcinoma	Anastrozole, Trastuzumab
EMA (1)	ERBB2 amplification	Invasive Breast Carcinoma	Anastrozole, Trastuzumab
HSE (2)	ER positive, HER2-positive, PR positive	Invasive Breast Carcinoma	Anastrozole
HSE (2)	ER positive, HER2-positive	Invasive Breast Carcinoma	Anastrozole
HSE (2)	HER2-positive, PR positive	Invasive Breast Carcinoma	Anastrozole
HSE (1)	ER positive, HER2-positive, PR positive	Invasive Breast Carcinoma	Anastrozole, Trastuzumab
HSE (1)	ER positive, HER2-positive	Invasive Breast Carcinoma	Anastrozole, Trastuzumab
HSE (1)	HER2-positive, PR positive	Invasive Breast Carcinoma	Anastrozole, Trastuzumab
HPRA (3) HSE (1)	ER positive	Invasive Breast Carcinoma	Anastrozole
HPRA (3) HSE (1)	PR positive	Invasive Breast Carcinoma	Anastrozole
HPRA (3) HSE (1)	ER positive, PR positive	Invasive Breast Carcinoma	Anastrozole